Publication | Closed Access
ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐<scp>d</scp>‐GLUCOSE
164
Citations
31
References
1973
Year
Glucose UptakeCerebral Vascular RegulationMetabolic SyndromeNeurologyHuman MetabolismHealth SciencesPhosphate ConcentrationCerebral Blood FlowPharmacologyEnergy MetabolismBrain GlucoseNeurophysiologyPhysiologyDiabetesBlood Glucose MonitoringDiabetes MellitusHyperglycemiaMetabolismMedicine
Abstract —The time course of effects of 2‐deoxy‐ d ‐glucose on cerebral glucose metabolism has been studied in vivo and the inhibitory actions of 2‐deoxy‐ d ‐glucose and 2‐deoxy‐ d ‐glucose‐6‐phosphate on cerebral glycolytic enzymes in vitro . Mice were given 2‐deoxy‐ d ‐glucose 3 g/kg intraperitoneally. Blood 2‐deoxy‐ d ‐glucose/glucose ratio was 2–3 from 5 to 30 min after injection, the hyperglycaemic response to 2‐deoxy‐ d ‐glucose having been suppressed with propranolol. Maximal cerebral 2‐deoxy‐ d ‐glucose uptake observed was 1μ11 μmol/g/min between 5 and 10 min after injection. At 10 min brain concentrations of 2‐deoxy‐ d ‐glucose and 2‐deoxy‐ d ‐glucose‐6‐phosphate were 5·82 and 3·12 μmol/g. Analysis of the fate of d ‐[U‐ 14 C] glucose given subcutaneously 5 min before death showed that glucose uptake was reduced to 40–60 per cent of control from 5 to 30 min after 2‐deoxy‐ d ‐glucose. However brain glucose concentration rose three to five‐fold 20–30 min after 2‐deoxy‐ d ‐glucose. The majority of glucose entering the brain after 10 min of 2‐deoxy‐ d ‐glucose treatment was recovered as glucose. Conversion of brain glucose to other acid soluble components was reduced to 1/3 at 10 min and 1/5 at 20–30 min. Glucose‐6‐phosphate concentration rose from 5 min onwards and was maintained at twice control concentration from 10–30 min. However, because of the rapid entry of 2‐deoxy‐ d ‐glucose and its conversion to 2‐deoxy‐ d ‐glucose‐6‐phosphate, the 2‐deoxy‐ d ‐glucose 6‐P/glucose 6‐P ratio was between 19 and 32. Brain adenosine triphosphate concentration did not change, creatine phosphate concentration fell after 25 min. Measurement of enzyme activities in cerebral homogenates (using 1 mivs substrate concentration) showed that hexokinase (EC 2.7.1.1) was 40 per cent inhibited by 5 m m ‐deoxy‐ d ‐glucose (but not by 2‐deoxy‐ d ‐glucose 6‐P). Glucose 6‐P dehydrogenase (EC 1.1.1.49), 6‐phosphogluconate dehydrogenase (EC 1.1.1.43) and phosphoglucomutase (EC 2.7.5.1) were not affected by either 2‐deoxy‐ d ‐glucose (5 m m ) or 2‐deoxy‐ d ‐glucose 6‐P (5 or 20 m m ). Hexose‐phosphate isomerase (EC 5.3.1.9) was 70 per cent inhibited by 20 m m ‐ d ‐deoxy‐ d ‐glucose 6‐P. Phosphofructokinase (EC 2.7.1.11) was inhibited by 17 per cent by 2‐deoxy‐ d ‐glucose 6‐P (20 m m ). During the initial impairment of cerebral function by 2‐deoxy‐ d ‐glucose there is competitive inhibition of glucose transport into the brain; later, glycolysis is more powerfully depressed by the inhibition of isomerase produced by the high intracerebral concentration of 2‐deoxyglucose‐6‐phosphate.
| Year | Citations | |
|---|---|---|
Page 1
Page 1